Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,307 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Active, Not Recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

NCT06275724

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +12 more
Locations
  • Novartis Investigative Site Handa, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 107 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

NCT04020055

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +32 more
Locations
  • Emory University Atlanta, Georgia, United States
  • The Cleveland Clinic Cleveland, Ohio, United States
  • Lysosomal and Rare Disorders Research and Treatment Center, Inc Fairfax, Virginia, United States
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Active, Not Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

NCT05739383

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +24 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • UAB St Vincents Birmingham, Alabama, United States
  • Eastern Shore Research Institute Fairhope, Alabama, United States
  • G and L Research LLC Foley, Alabama, United States
View all 986 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease

NCT03737214

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alabama at Birmingham - Nephrology Research Clinic Birmingham, Alabama, United States
  • University of California Irvine Irvine, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • University of Florida Clinical and Translational Science Institute, UF Clinical Research Center Gainesville, Florida, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

Cerliponase Alfa Observational Study in the US

NCT04476862

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis

NCT04713475

Conditions
Beta-Galactosidase-1 (GLB1) Deficiency, Brain Diseases, Brain Diseases, Metabolic, +23 more
Locations
  • Benioff Children's Hospital Oakland, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Children's Hospital at St. Peter's University Hospital New Brunswick, New Jersey, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

NCT06347133

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • Research Site 1 Birmingham, Alabama, United States
  • Research Site 2 Mobile, Alabama, United States
  • Research Site 3 Beverly Hills, California, United States
  • Research Site 4 Canoga Park, California, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

NCT07216482

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Central Research Associates ( Site 0009) Birmingham, Alabama, United States
  • G&L Research ( Site 0024) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc. - Phoenix Central ( Site 0030) Phoenix, Arizona, United States
  • Alliance for Multispecialty Research LLC ( Site 0049) Tempe, Arizona, United States
View all 89 locations
View Trial Details

Related conditions